Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Haoxi Health Technology Ltd
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
F-1/A | Document | Amendment to Registration statement for securities of certain foreign private issuers Acc-no: 0001213900-24-067427 (33 Act) Size: 3427 KB |
Aug-12-2024 | 241195165 |
F-1/A | Document | Amendment to Registration statement for securities of certain foreign private issuers Acc-no: 0001013762-24-003261 (33 Act) Size: 3694 KB |
Jul-31-2024 | 241162560 |
F-1/A | Document | Amendment to Registration statement for securities of certain foreign private issuers Acc-no: 0001213900-24-063842 (33 Act) Size: 3359 KB |
Jul-24-2024 | 241136954 |
F-1/A | Document | Amendment to Registration statement for securities of certain foreign private issuers Acc-no: 0001213900-24-062519 (33 Act) Size: 4495 KB |
Jul-18-2024 | 241124678 |
F-1/A | Document | Amendment to Registration statement for securities of certain foreign private issuers Acc-no: 0001213900-24-061188 (33 Act) Size: 4763 KB |
Jul-15-2024 | 241115997 |
F-1 | Document | Registration statement for securities of certain foreign private issuers Acc-no: 0001213900-24-052441 (33 Act) Size: 5375 KB |
Jun-13-2024 | 241041254 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-048183 (34 Act) Size: 90 KB |
May-31-2024 | 241007755 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-040248 (34 Act) Size: 246 KB |
May-07-2024 | 24919712 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-039318 (34 Act) Size: 48 KB |
May-03-2024 | 24910845 |
DRS | Document | Acc-no: 0001213900-24-023138 (33 Act) Size: 4612 KB | Mar-15-2024 | 24756095 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-020938 (34 Act) Size: 10 KB |
Mar-08-2024 | 24733249 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-008008 (34 Act) Size: 34 KB |
Jan-30-2024 | 24579559 |
424B4 | Document | Prospectus filed pursuant to Rule 424(b)(4) Acc-no: 0001213900-24-007207 (33 Act) Size: 2468 KB |
Jan-29-2024 | 24570818 |
EFFECT | Document | Acc-no: 9999999995-24-000205 (33 Act) Size: 1 KB | Jan-25-2024 | 24563978 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001213900-24-005972 ( Act) Size: 7 KB |
Jan-24-2024 | |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001213900-24-005971 ( Act) Size: 12 KB |
Jan-24-2024 | |
CERT | Document | Acc-no: 0001354457-24-000029 (34 Act) Size: 213 KB | Jan-24-2024 | 24555218 |
8-A12B | Document | Form for the registration / listing of a class of securities on a national securities exchange pursuant to section 12(b) Acc-no: 0001213900-24-005918 (34 Act) Size: 20 KB |
Jan-24-2024 | 24554760 |
F-1/A | Document | Amendment to Registration statement for securities of certain foreign private issuers Acc-no: 0001213900-24-005514 (33 Act) Size: 748 KB |
Jan-23-2024 | 24550884 |
F-1/A | Document | Amendment to Registration statement for securities of certain foreign private issuers Acc-no: 0001213900-23-095951 (33 Act) Size: 149 KB |
Dec-15-2023 | 231489192 |
Recent 20 filings. View all Haoxi Health Technology Ltd filings
young lad who new his job ansered questions and new what was best for me.
Very good communication and delivery made within the timeframe I was advised of
Huge help thank you for your help .. y'all make it so much easier
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by